- Conditions
- 22q11.2 Deletion Syndrome, Autism Spectrum Disorder, Autism Spectrum Disorder (ASD, Cerebral Palsy (CP), Cerebral Palsy Hemiparetic Cerebral Palsy Spasticity Gait Disorders, Neurologic Postural Balance Impairment, Cerebral Palsy Infantile, Cerebral Palsy Spastic Hemiplegic, Cerebral Palsy, Dyskinetic, Chromosomal Abnormalities, Developmental Delay (Disorder), Down Syndrome (Trisomy 21), Fragile X Syndrome (FXS), Genetic Disorders, Hypoxic Ischemic Encephalopathy, Hypoxic Ischemic Encephalopathy (HIE), Neurodevelopmental Disorders, Neurodevelopmental Disorders (NDD), Neurodevelopmental Disorders and Developmental Abnormalities, RETT Syndrome With Proven MECP2 Mutation, Sensorimotor Integration, Sensory Processing Disorder, Traumatic Brain Injury (TBI), Williams Syndrome
- Interventions
- Not listed
- Lead sponsor
- Healing Hope International
- Other
- Eligibility
- 4 Years to 12 Years
- Enrollment
- 100 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2026 – 2036
- U.S. locations
- 1
- States / cities
- The Woodlands, Texas
Source: ClinicalTrials.gov public record
Updated Mar 24, 2026 · Synced May 21, 2026, 12:34 AM EDT